Leading the Way in Life Science Technologies

GEN Exclusives

More »


More »

For full access to this article login to GEN Select now.

April 01, 2014 (Vol. 34, No. 7)

Fighting Kidney Toxicity: The Case for Better Biomarkers

  • Burdened with the demands of handling waste, the kidneys are particularly susceptible to drug-induced toxicity. So it’s no surprise that pharma companies are increasingly finding nephrotoxicity to be a major cause of failure of candidate compounds during drug development, aiding in the downward spiral toward organ failure. Therefore, biomarkers ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.